跳至主要内容
临床试验/ACTRN12622001258741
ACTRN12622001258741尚未招募未知

Evaluating the effect of topical application of gel containing high concentrations of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) with stannous fluoride on white spot lesions in enamel in situ in healthy adults

niversity of Melbourne0 个研究点目标入组 4 人开始时间: 2022年9月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
4

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Inclusion Criteria
  • Age range: 18 to 75 years.
  • Gender: Males and females.
  • Good general health.
  • At least 22 natural teeth
  • A gum- stimulated whole salivary flow rate at least 1.0 ml/minute and unstimulated whole salivary flow rate at least 0.2 ml/minute.
  • Available for both treatment periods.

排除标准

  • The exclusion criteria include:
  • 1) History of adverse or allergic reactions to milk proteins (such as casein), tin or tin-containing products, or any other ingredients in the
  • 2) Orthodontic appliances or removable dentures;
  • 3) Veneers, or more than one incisor with an artificial crown;
  • 4) Oral diseases including advanced periodontal disease;
  • 5) Chronic disease such as diabetes or use of medications that cause gum swelling;
  • 6) Untreated decay;
  • 7) Treatment with antibiotics or anti-inflammatory medicines in the month prior to starting the study;
  • 8) Use of drugs that may interact with the toothpaste slurries or which may affect salivary flow rate;
  • 9) History of health conditions requiring antibiotic coverage prior to dental treatment;
  • 10) Pregnancy/lactation;
  • 11) Serious infectious disease;
  • 12) Any other medical or dental condition deemed to put the health and wellbeing of you or the research team at risk if you participated in

研究者

发起方
niversity of Melbourne

相似试验